Morningstar® Stock Report™

Regeneron Pharmaceuticals Inc REGN

Balance Sheet Items (in % Terms)
20192020202120222023
Cash & Short Term Investments21.71%20.90%22.39%26.50%32.78%
Deudores18.05%20.49%23.73%18.24%17.13%
Existencias9.56%11.17%7.67%8.22%7.80%
Otros activos corrientes2.61%4.42%1.31%1.41%1.17%
Total activos corrientes51.94%56.98%55.10%54.37%58.88%
Net PP&E19.52%18.77%13.69%12.88%12.53%
Intangibles---3.13%3.14%
Otros activos a largo plazo28.54%24.25%31.21%29.62%25.44%
Total Activo 100.00%100.00%100.00%100.00%100.00%
Accounts Payable2.82%2.77%2.22%2.02%1.83%
Deuda corriente-----
Impuestos a pagar0.33%0.11%1.28%0.00%-
Accrued liabilities7.01%8.75%6.26%7.06%7.13%
Otro pasivo corriente4.00%4.08%5.70%1.67%1.39%
Total pasico corriente14.16%15.72%15.46%10.75%10.35%
Deuda a largo plazo-11.53%7.78%6.78%5.99%
Otras deudas a largo plazo-----
Total Pasivo-----
Fondos propios totales74.90%64.24%73.79%77.58%78.52%
Total Liabilities and Equity100.00%100.00%100.00%100.00%100.00%
Liquidity/Financial Health
20192020202120222023
Current Ratio3.673.633.565.065.69
Quick Ratio2.812.862.984.164.82
Financial Leverage1.341.561.361.291.27
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures